These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22165629)

  • 1. [Case-report: toxic epidermal necrolysis].
    Namdar T
    MMW Fortschr Med; 2011 Mar; 153(11):44-5. PubMed ID: 22165629
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
    [No Abstract]   [Full Text] [Related]  

  • 3. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic Epidermal Necrolysis in a Pediatric Patient.
    Hagen S; Grey K; Hylwa S
    Minn Med; 2016; 99(3):49-50. PubMed ID: 27323526
    [No Abstract]   [Full Text] [Related]  

  • 5. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of toxic epidermal necrolysis in a 15-year-old girl.
    Clennett S; Hosking G
    J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.
    Wolkenstein P; Wilson YT
    Br J Dermatol; 2016 Jun; 174(6):1171-3. PubMed ID: 27317272
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong.
    Ying S; Ho W; Chan HH
    Burns; 2001 Jun; 27(4):372-5. PubMed ID: 11348746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis clinical guidelines.
    Endorf FW; Cancio LC; Gibran NS
    J Burn Care Res; 2008; 29(5):706-12. PubMed ID: 18695603
    [No Abstract]   [Full Text] [Related]  

  • 11. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 15-year review of pediatric toxic epidermal necrolysis.
    Quirke KP; Beck A; Gamelli RL; Mosier MJ
    J Burn Care Res; 2015; 36(1):130-6. PubMed ID: 25501779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis.
    Wolkenstein P; Revuz J
    Dermatol Clin; 2000 Jul; 18(3):485-95, ix. PubMed ID: 10943543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Oliveira A; Sanches M; Selores M
    Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of drug-induced toxic epidermal necrolysis.
    Eisen ER; Fish J; Shear NH
    J Cutan Med Surg; 2000 Apr; 4(2):96-102. PubMed ID: 11179933
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-threatening Skin Disorders Treated in the Burn Center: Impact of Health care-associated Infections on Length of Stay, Survival, and Hospital Charges.
    Hermiz SJ; Diegidio P; Ortiz-Pujols S; Garimella R; Weber DJ; van Duin D; Hultman CS
    Clin Plast Surg; 2017 Jul; 44(3):597-602. PubMed ID: 28576248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 20. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.